M&A Deal Summary |
|
|---|---|
| Date | 2013-07-23 |
| Target | Advanced Liquid Logic |
| Sector | Medical Products |
| Buyer(s) | Illumina |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1998 |
| Sector | Life Science |
| Employees | 10,590 |
| Revenue | 4.4B USD (2024) |
Illumina is a developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. Illumina provides innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA, and protein. Illumina was formed in 1998 and is based in San Diego, California.
| DEAL STATS | # |
|---|---|
| Overall | 6 of 30 |
| Sector: Medical Products M&A | 2 of 3 |
| Type: Add-on Acquisition M&A Deals | 6 of 14 |
| State: North Carolina M&A | 1 of 1 |
| Country: United States M&A | 5 of 21 |
| Year: 2013 M&A | 2 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-01-07 |
Artemis Health
Salt Lake City, Utah, United States Artemis Health is a provider of benefits data analytics and healthcare analytics to self-insured employers, employee benefits consultants, and benefits brokers. Artemis Health was founded in 2002 and is based in Salt Lake City, Utah. |
Buy | $450M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-10-28 |
NextBio
Santa Clara, California, United States NextBio, Inc. is a provider of clinical and genomic informatics. NextBio's powerful big-data platforms aggregate and analyze large quantities of phenotypic and genomic data for research and clinical applications. |
Buy | - |
